This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

S&P Capital IQ To Share Its Views On The Biotech Bull Market During The Next "ETF Analyst Hour"

NEW YORK, Oct. 21, 2013 /PRNewswire/ -- Biotechnology has been one of the strongest performing industries through the first three quarters of 2013, returning 58.3% versus 18.6% for the S&P 500™ index as of September 30, 2013. On Wednesday, October 23 rd at 11am EDT, S&P Capital IQ will host a webinar to discuss the factors that have been driving the biotech bull market and whether it's set to continue its run in the months to come.

This webinar, part of the S&P Capital IQ "ETF Analyst Hour" series, will be titled "Biotech Bull Market: How Long Can It Last?" and will feature Steve Silver, Senior Industry Analyst at S&P Capital IQ, providing an overview of the biotech industry, including the factors that have been contributing to its strong recent performance. Silver will be joined by Todd Rosenbluth, S&P Capital IQ's Director of ETF and Mutual Fund Research, who will share his insights on the pros and cons of biotech-specific ETFs and how much exposure to biotech investors may be able to obtain through more diversified ETFs.

This webinar is the latest in S&P Capital IQ's monthly ETF Analyst Hour series and one hour of CFP continuing education credit is available to attendees. Interested attendees can register here: http://bit.ly/18WZTfc  

Anthony Hohmann, ETF product manager, will moderate the discussion and highlight S&P Capital IQ's ETF holdings-based ranking methodology and model performance to date.

Following the presentation, the ETF research reports for the ETFs discussed will be available to all attendees. The ETF reports are initially published on S&P Capital IQ's MarketScope Advisor platform.

Follow @spmarketscope and #ETFHour during the webinar for up-to-the-second ETF commentary from S&P Capital IQ equity analysts.

About S&P Capital IQS&P Capital IQ, a business line of McGraw Hill Financial (NYSE: MHFI), is a leading provider of multi-asset class and real time data, research and analytics to institutional investors, investment and commercial banks, investment advisors and wealth managers, corporations and universities around the world. Evaluated pricing is prepared by Standard & Poor's Securities Evaluations, Inc., a part of S&P Capital IQ and a registered investment adviser with the U.S. Securities & Exchange Commission.  S&P capital IQ  provides a broad suite of capabilities designed to help track performance, generate alpha, and identify new trading and investment ideas, and perform risk analysis and mitigation strategies. Through leading desktop solutions such as the S&P Capital IQ, Global Credit Portal and MarketScope Advisor desktops; enterprise solutions such as S&P Capital IQ Valuations; and research offerings, including Leveraged Commentary & Data, Global Markets Intelligence, and company and funds research, S&P Capital IQ sharpens financial intelligence into the wisdom today's investors need. For more information visit www.spcapitaliq.com.

Standard & Poor's Financial Services LLC, its affiliates (together, S&P) or their third-party providers do not guarantee the accuracy, completeness or timeliness of any information, including model, software or application, they provide, and are not responsible for errors and omissions (negligent or otherwise), or for the results obtained from the use of such information.  S&P and its third party providers disclaim any and all express or implied warranties. 

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs